Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The list of medical technologies approved for innovation funding (NUB) in Germany in 2020

On January 30, 2020, the Institute for the Hospital Remuneration System (InEK) has published the List of the requests for innovation funding (NUB), submitted by the hospitals until October 31, 2019. Out of 778 technologies, 201 (26%) received the positive status 1, which means that the evaluated procedure or medical device meets the NUB criteria and allows the hospitals to negotiate with the sickness funds for the innovation funding for these technologies.

The full list of 78 technologies, which obtained the status 1, is provided below:

  1. Insertion of coated (covered) stents with a bioactive surface for peripheral vessels
  2. Covered endoprosthesis with a bioactive surface for dialysis shunt revision
  3. External stabilization scaffold for anastomosis of an AV shunt as part of shunt surgery
  4. Ascites treatment using a fully implantable pump
  5. Endovascular system of an internal AV shunt using magnetically guided radiofrequency energy
  6. Intra-aneurysmal hemodynamically effective implant for endovascular treatment of intracranial aneurysms
  7. Hemodynamically effective implant for the endovascular treatment of intracranial aneurysms and brain-supplying neck vessels
  8. Removable, ultra-soft microcoils for intracranial therapy of vascular malformations and aneurysms
  9. Flow-reducing wire mesh in the coronary sinus
  10. Gastric pacemaker implantation
  11. Selective intravascular radionuclide therapy (SIRT) with holmium 166-labeled microspheres for radioembolization
  12. Endovascular implantation of an extracorporeal centrifugal pump for circulatory support
  13. The intra-aortic catheter with paracorporeal membrane pump for circulatory support of the left ventricle
  14. Extracorporeal neurostimulation system for the peripheral nervous system
  15. Focal photodynamic therapy with padeliporfin for the treatment of localized prostate cancer
  16. Endovascular mitral valve annuloplasty with an annuloplasty band
  17. Lung volume reduction using a bronchoscopic application of polymer foam
  18. Transcatheter implantation of an interatrial shunt device for the treatment of heart failure
  19. Percutaneous transluminal insertion of an atrial septal implant
  20. Endo-barrier for the treatment of obese type 2 diabetics
  21. Hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea syndrome (OSAS)
  22. Transapical mitral valve reconstruction by implantation of neochordae (PTFE)
  23. Therapy of scoliosis using magnetically controlled rods
  24. Temporomandibular joint endoprosthesis (total replacement)
  25. Transfer of virus-specific donor immune cells after allogeneic stem cell transplantation
  26. Minimally invasive LV-reconstruction with a myocardial anchoring system
  27. Mesenchymal stem cells
  28. Administration of CAR-T cells for the treatment of hematological diseases
  29. Intra-aortal balloon occlusion with extracorporeal circulation
  30. Catheter-based implant for the treatment of left ventricular cardiac motility disorders
  31. Wireless left ventricular cardiac pacing system for cardiac resynchronization therapy
  32. Vertebral bodies growth modulation technique
  33. Implantation of growing heart valves
  34. Endo-Exo-Prostheses
  35. Therapy of scoliosis using a screw and rod system that grows with the patient
  36. Replacement of the pulmonary trunk or parts of the aorta with an acellular allograft
  37. Insertion of coated (covered) stents with a bioactive surface for peripheral and other vessels
  38. Insertion of coated (covered) stents with a bioactive surface for intraabdominal, cranial or peripheral vessels
  39. Implant for direct acoustic stimulation of the cochlea (DACI)
  40. Apicoaortal valve-carrying conduit
  41. Radioligand therapy with Actinium-225-PSMA-ligands
  42. Insertion of coated (covered) stents with a bioactive surface for visceral and supra-aortic vessels
  43. Endovascular forming of a peripheral AV fistula via direct current
  44. Intracavitary radiotherapy with Iodine-125
  45. Fetoscopic drainage therapy
  46. Acoustic neurinoma surgery with simultaneous cochlear implantation
  47. Epiretinal retinal prosthesis
  48. Radioimmunotherapy with anti-CD19, anti-CD45, and anti-CD66 antibodies
  49. Endovascular mitral valve annuloplasty with seam anchoring
  50. Fetoscopic tracheal balloon occlusion in diaphragmatic hernia and premature bladder rupture
  51. Pulmonary arterial banding, telemetrically adjustable
  52. Closure of umbilical cord and intrafetal vessels by percutaneous ultrasound-controlled radiofrequency ablation or fetoscopic laser ablation
  53. Lutetium-177- or Yttrium-90-pentixafor therapy
  54. Boston keratoprosthesis
  55. Fetoscopic opening of narrowed semilunar valves and the foramen ovale
  56. Auditory brainstem implant
  57. Fetoscopic therapy of fetal supraventricular tachycardia and larynx or trachea occlusion
  58. Keratoprosthesis, biologically coated
  59. Radionuclide therapy with lutetium-177-bisphosphonate in bone metastases of prostate cancer
  60. Uterine shield closure after fetoscopic interventions
  61. Growth endoprosthesis
  62. Allogenic hepatocytes transplantation
  63. Continuous amniotic infusion using the subcutaneously implanted port system
  64. Percutaneous caval valve stent placement
  65. Subretinal active implant
  66. Auditory midbrain implant
  67. Forming of a sleeve stomach (sleeve resection), endoscopic
  68. Artificial larynx after total laryngectomy
  69. Percutaneous-transthoracic tricuspid valve replacement
  70. Radionuclide therapy with Iodine-131-azetidinylamide in metastatic adrenal carcinoma
  71. Uterus transplantation
  72. Autologous matrix-induced hepatocytes transplantation
  73. Treatment of fatal epidermolysis bullosa junctionalis (M. Herlitz type) by transplantation of haploidentical bone marrow and skin of the same donor
  74. Treatment of children with rhabdomyosarcomas of the bladder/prostate/rectum / perineal region with organ-preserving surgery and interstitial HDR brachytherapy
  75. Joint transplants with thin-layered, fresh, living, allogeneic cartilage or bone material
  76. Combined renal and stem cell transplantation (living donation)
  77. Radionuclide therapy with Iodine-131-metomidate
  78. Complete face transplantation.

Nine new technologies (percutaneous transluminal insertion of an atrial septal implant, mesenchymal stem cells, replacement of the pulmonary trunk or parts of the aorta with an acellular allograft, endovascular forming of a peripheral AV fistula via direct current, Boston keratoprosthesis, percutaneous caval valve stent placement, forming of a sleeve stomach (sleeve resection), endoscopic, percutaneous-transthoracic tricuspid valve replacement, joint transplants with thin-layered, fresh, living, allogeneic cartilage or bone material) received status 1 in comparison with the list presented in 2019.

Furthermore, one procedure (implantation of an intracardiac pulse generator) with status 1 in 2019, received status 2 in 2020.

The full details in German can be found here.

Visit our online school if you want to learn about innovative payment schemes for medical technologies.

This is a syndicated report (>100 pages) with the overview and statistics of key innovation funding and coverage with evidence development schemes in seven European countries (Austria, Belgium, England, France, Germany, the Netherlands and Switzerland)

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.